Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Botulinum Toxin Type A Injection [Botox]
The First People's Hospital of Lianyungang
Rosacea
1 trial -
Brahmi
Unilever Australia Limited
Cognition
1 trial -
Breast MRI interpretation
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Breztri Aerosphere
The First People's Hospital of Lianyungang
Lung Cancer, Nonsmall Cell
1 trial -
Bright Changyou probiotic flavored yogurt
BRIGHT MINDS BIOSCIENCES INC.
Intestinal Health
1 trial -
Bright Momchilovtsi Yogurt
BRIGHT MINDS BIOSCIENCES INC.
Constipation
1 trial -
Bromocriptin 2.5mg, 2-3 times a day
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pituitary Tumor
1 trial -
Budesonide/formoterol
The First People's Hospital of Lianyungang
COPD Exacerbation
1 trial -
Bufei Recipe
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Preserved Ratio Impaired Spirometry
1 trial -
Bundle Group 1 with Nutrilite Lifestyle
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial -
Bupivacain
Hospital Authority, Hong Kong
Arthroplasty, Replacement, Knee
1 trial -
Bupivacaine / fentaNYL
Grace Therapeutics
Depression, Postpartum
1 trial -
Buprenorphine/naloxone
BRIGHT MINDS BIOSCIENCES INC.
Human Immunodeficiency Virus
1 trial -
Buprenorphine/naloxone
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis C
1 trial -
Bupropion
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Bupropion
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Buspirone
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use Disorders
1 trial -
Buspirone
The First People's Hospital of Lianyungang
Anxiety Disorders
1 trial -
Butorphanol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Visceral Pain
1 trial -
Buyang Huanwu Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Glaucoma
1 trial -
CAR-CD19 T cell
The First People's Hospital of Lianyungang
B Cell Lymphoma
1 trial -
CAR-T cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Philadelphia Positive Acute Lymphoblastic Leukemia
1 trial -
CD19 CAR T-cell
Universal Integrated
B-cell Acute Lymphoblastic Leukemia
1 trial -
CM (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Childhood Asthma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources